| According to Manhattan Research, there are 142.4 million consumers who have an extended impact on the healthcare decisions of their loved ones. Targeting these mega-influencers can help pharmas get their message to hard-to-reach populations. The Internet is an optimal venue for targeting them, says Erika S. Fishman, Manhattan Research senior analyst. "Compared to the general population, the mega-influencers are considerably more likely to go online in any capacity: go online for health, and go online for pharmaceutical information," she tells ePharm5. According to the study, the mega-influencers can impact another 152.9 million people, especially those with diabetes, hypertension, arthritis, heart disease, asthma, high cholesterol, chronic pain, and depression. |
0 comments:
Post a Comment